BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 186 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q3 2019. The put-call ratio across all filers is 0.14 and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $4,400,000 | -17.2% | 37,111 | -3.8% | 0.01% | -8.3% |
Q4 2021 | $5,316,000 | -8.1% | 38,577 | -7.4% | 0.01% | -20.0% |
Q3 2021 | $5,786,000 | +41.4% | 41,654 | -1.2% | 0.02% | +50.0% |
Q2 2021 | $4,093,000 | +32.6% | 42,154 | -6.6% | 0.01% | +11.1% |
Q1 2021 | $3,086,000 | -17.4% | 45,153 | +3.6% | 0.01% | -10.0% |
Q4 2020 | $3,737,000 | +29.8% | 43,603 | -1.5% | 0.01% | +11.1% |
Q3 2020 | $2,879,000 | -13.5% | 44,282 | -2.8% | 0.01% | -18.2% |
Q2 2020 | $3,329,000 | +107.2% | 45,536 | -3.6% | 0.01% | +57.1% |
Q1 2020 | $1,607,000 | -39.7% | 47,244 | -3.6% | 0.01% | -22.2% |
Q4 2019 | $2,667,000 | +27.5% | 49,002 | -2.2% | 0.01% | +12.5% |
Q3 2019 | $2,091,000 | – | 50,107 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |